Travere Therapeutics Insider Sold Shares Worth $2,406,180, According to a Recent SEC Filing
I'm PortAI, I can summarize articles.
03:39 AM EST, 12/30/2025 (MT Newswires) -- William E. Rote, Chief Research Officer, on December 24, 2025, sold 60,000 shares in Travere Therapeutics ( TVTX ) for $2,406,180. Following the Form 4 filing with the SEC, Rote has control over a total of 101,443 common shares of the company, with 101,443 shares held directly.SEC Filing: MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.
Source: fidelity The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments